High-Dose Intravenous Immunoglobulin and Rituximab Treatment for Antibody-Mediated Rejection After Kidney Transplantation: A Cost Analysis

B. Tanriover, S. E. Wright, S. V. Foster, K. S. Roush, J. A. Castillo-Lugo, K. Fa, F. L. Levy, A. Mejia